These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 21881031)

  • 21. Potential interaction involving warfarin and ritonavir.
    Knoell KR; Young TM; Cousins ES
    Ann Pharmacother; 1998 Dec; 32(12):1299-302. PubMed ID: 9876810
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A phase II trial of cisplatin and irinotecan alternating with doxorubicin, cyclophosphamide and etoposide in previously untreated patients with extensive-disease small-cell lung cancer.
    Tabata M; Kiura K; Okimoto N; Segawa Y; Shinkai T; Yonei T; Kuyama S; Harita S; Hotta K; Ueoka H; Tanimoto M
    Cancer Chemother Pharmacol; 2007 Jun; 60(1):1-6. PubMed ID: 17393168
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-term, low-intensity warfarin therapy for the prevention of recurrent venous thromboembolism.
    Ridker PM; Goldhaber SZ; Danielson E; Rosenberg Y; Eby CS; Deitcher SR; Cushman M; Moll S; Kessler CM; Elliott CG; Paulson R; Wong T; Bauer KA; Schwartz BA; Miletich JP; Bounameaux H; Glynn RJ;
    N Engl J Med; 2003 Apr; 348(15):1425-34. PubMed ID: 12601075
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impact of prophylactic oseltamivir on INR in patients on stable warfarin therapy.
    Smith KR; Bryan WE; Townsend ML; Randolph AE; Vanderman AJ; Woodard CL; Brown JN
    J Thromb Thrombolysis; 2020 Aug; 50(2):452-456. PubMed ID: 31898274
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Probable Interaction Between Warfarin and Banana Flakes Supplement.
    King AE; Strnad K
    Nutr Clin Pract; 2016 Feb; 31(1):125-31. PubMed ID: 26137942
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Elevated international normalized ratio associated with concomitant warfarin and erlotinib.
    Thomas KS; Billingsley A; Amarshi N; Nair BA
    Am J Health Syst Pharm; 2010 Sep; 67(17):1426-9. PubMed ID: 20720241
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Probable Interaction Between Warfarin and Inhaled and Oral Administration of Cannabis.
    Hsu A; Painter NA
    J Pharm Pract; 2020 Dec; 33(6):915-918. PubMed ID: 31319733
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Complications and risks associated with an anticoagulation therapy combining low molecular weight heparin and Warfarin after total replacement of large joints--our experience].
    Míka P; Behounek J; Skoták M; Nevsímal L
    Acta Chir Orthop Traumatol Cech; 2004; 71(4):237-44. PubMed ID: 15456102
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prospective assessment of a nomogram for the initiation of oral anticoagulation therapy for outpatient treatment of venous thromboembolism.
    Kovacs MJ; Anderson DA; Wells PS
    Pathophysiol Haemost Thromb; 2002; 32(3):131-3. PubMed ID: 12372927
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluating warfarin management by pharmacists in a community teaching hospital.
    Chilipko AA; Norwood DK
    Consult Pharm; 2014 Feb; 29(2):95-103. PubMed ID: 24513419
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of an initiation protocol of 4 mg of warfarin for atrial fibrillation in the outpatient setting.
    Sridhar VS; Leung P; Seymour N; Nagge J
    Can Fam Physician; 2014 Nov; 60(11):e535-40. PubMed ID: 25551135
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hemorrhagic events lead to an increase in international normalized ratio in patients on warfarin.
    Perona S; Ford M; Rindone J
    J Pharm Pract; 2011 Oct; 24(5):494-7. PubMed ID: 22156711
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [INTERNATIONAL NORMALIZED RATIO VALUES AND HEMORRHAGE IN HOSPITALIZED PATIENTS STARTING WARFARIN THERPY: AN OBSERVATIONAL STUDY].
    Abadi U; Ellis MH
    Harefuah; 2015 Aug; 154(8):490-3, 541-2. PubMed ID: 26480611
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Interaction between warfarin and nafcillin: case report and review of the literature.
    Kim KY; Frey RJ; Epplen K; Foruhari F
    Pharmacotherapy; 2007 Oct; 27(10):1467-70. PubMed ID: 17896903
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Phase I study of weekly alternating therapy with irinotecan/cisplatin and etoposide/cisplatin for patients with small-cell lung cancer.
    Johnson FM; Kurie JM; Peeples BO; Lee JJ; Feng L; Pisters KM; Fossella FV; Papadimitrakopoulou VA; Blumenschein GR; Komaki R; Glisson BS
    Clin Lung Cancer; 2003 Jul; 5(1):40-5. PubMed ID: 14596703
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dosing options for decreasing the time to achieve therapeutic anticoagulation when reinitiating warfarin: a case series.
    Schultz KT; Bungard TJ
    Pharmacotherapy; 2011 Aug; 31(8):793-805. PubMed ID: 21923606
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Elevated International Normalized Ratio in a Patient Taking Warfarin and Mauby: A Case Report.
    Sorbera M; Joseph T; DiGregorio RV
    J Pharm Pract; 2017 Oct; 30(5):567-570. PubMed ID: 27543375
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Patient case: impact of smoking cessation on international normalized ratio.
    Jordan SD; Stone MD; Alexander E; Haley J; McKee A
    J Pharm Pract; 2014 Oct; 27(5):470-3. PubMed ID: 24395009
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Thromboembolic consequences of subtherapeutic anticoagulation in patients stabilized on warfarin therapy: the low INR study.
    Clark NP; Witt DM; Delate T; Trapp M; Garcia D; Ageno W; Hylek EM; Crowther MA;
    Pharmacotherapy; 2008 Aug; 28(8):960-7. PubMed ID: 18657012
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interaction between gemfibrozil and warfarin: case report and review of the literature.
    Dixon DL; Williams VG
    Pharmacotherapy; 2009 Jun; 29(6):744-8. PubMed ID: 19476425
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.